PARMAR VINENDRA M; GOSWAMI SUNITA S. EFFICACY AND SAFETY OF TENELIGLIPTIN AS ADD-ON THERAPY TO CONVENTIONAL THERAPY IN INDIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Asian Journal of Pharmaceutical and Clinical Research, [S. l.], v. 12, n. 12, p. 116–120, 2019. DOI: 10.22159/ajpcr.2019.v12i12.35952. Disponível em: https://journals.innovareacademics.in/index.php/ajpcr/article/view/35952. Acesso em: 9 may. 2024.